Combining TF profiling and in vitro TAM differentiation assays, we confirmed that PPARγ is a driving molecule of the terminal differentiation of MMP9+ TAMs and subsequently promotes HCC progression. The gene discussed is PPARG; the disease is hepatocellular carcinoma.